148 related articles for article (PubMed ID: 38586882)
21. Potential inhibitors for FKBP51: an
Barge S; Jade D; Ayyamperumal S; Manna P; Borah J; Nanjan CMJ; Nanjan MJ; Talukdar NC
J Biomol Struct Dyn; 2022; 40(24):13799-13811. PubMed ID: 34709133
[TBL] [Abstract][Full Text] [Related]
22. Plant derived active compounds as potential anti SARS-CoV-2 agents: an
Kashyap D; Jakhmola S; Tiwari D; Kumar R; Moorthy NSHN; Elangovan M; Brás NF; Jha HC
J Biomol Struct Dyn; 2022; 40(21):10629-10650. PubMed ID: 34225565
[TBL] [Abstract][Full Text] [Related]
23. Potential inhibitory activity of phytoconstituents against black fungus:
Hamaamin Hussen N; Hameed Hasan A; Jamalis J; Shakya S; Chander S; Kharkwal H; Murugesan S; Ajit Bastikar V; Pyarelal Gupta P
Comput Toxicol; 2022 Nov; 24():100247. PubMed ID: 36193218
[TBL] [Abstract][Full Text] [Related]
24. Exploring EGFR inhibitors with the aid of virtual screening, docking, and dynamics simulation studies.
Rehman ZU; Najmi A
J Biomol Struct Dyn; 2023 Sep; ():1-21. PubMed ID: 37707987
[TBL] [Abstract][Full Text] [Related]
25. Pharmacophore based virtual screening for identification of effective inhibitors to combat HPV 16 E6 driven cervical cancer.
Mohan A; Krishnamoorthy S; Sabanayagam R; Schwenk G; Feng E; Ji HF; Muthusami S
Eur J Pharmacol; 2023 Oct; 957():175961. PubMed ID: 37549730
[TBL] [Abstract][Full Text] [Related]
26. Flavonoids as promising anticancer agents: an
Biharee A; Yadav A; Jangid K; Singh Y; Kulkarni S; Sawant DM; Kumar P; Thareja S; Jain AK
J Biomol Struct Dyn; 2023; 41(16):7835-7846. PubMed ID: 36165610
[TBL] [Abstract][Full Text] [Related]
27. Exploring binding potential of two new indole alkaloids from
Rathod S; Shinde S; Choudhari P; Sarkate A; Chaudhari S; Shingan A
Nat Prod Res; 2024 Jan; ():1-8. PubMed ID: 38206888
[TBL] [Abstract][Full Text] [Related]
28. Identification of potential inhibitors against
Gaur V; Kumar N; Vyas A; Chowdhury D; Singh J; Bera S
J Biomol Struct Dyn; 2023 Dec; ():1-11. PubMed ID: 38149858
[TBL] [Abstract][Full Text] [Related]
29. Chemical Characterization,
Ansari JA; Ahmad MK; Fatima N; Azad I; Mahdi AA; Satyanarayan GNV; Ahmad N
Anticancer Agents Med Chem; 2022; 22(20):3416-3437. PubMed ID: 35125087
[TBL] [Abstract][Full Text] [Related]
30. Molecular docking and dynamics based approach for the identification of kinase inhibitors targeting PI3Kα against non-small cell lung cancer: a computational study.
Halder D; Das S; R A; R S J
RSC Adv; 2022 Jul; 12(33):21452-21467. PubMed ID: 35975074
[TBL] [Abstract][Full Text] [Related]
31. Computer-assisted drug discovery of potential natural inhibitors of the SARS-CoV-2 RNA-dependent RNA polymerase through a multi-phase
Elkaeed EB; Alsfouk BA; Ibrahim TH; Arafa RK; Elkady H; Ibrahim IM; Eissa IH; Metwaly AM
Antivir Ther; 2023 Oct; 28(5):13596535231199838. PubMed ID: 37669909
[TBL] [Abstract][Full Text] [Related]
32. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
[TBL] [Abstract][Full Text] [Related]
33. Protein reliability analysis and virtual screening of natural inhibitors for SARS-CoV-2 main protease (M
Kapusta K; Kar S; Collins JT; Franklin LM; Kolodziejczyk W; Leszczynski J; Hill GA
J Biomol Struct Dyn; 2021 Oct; 39(17):6810-6827. PubMed ID: 32795148
[TBL] [Abstract][Full Text] [Related]
34. Pharmacoinformatics-based identification of potential bioactive compounds against Ebola virus protein VP24.
Kwofie SK; Broni E; Teye J; Quansah E; Issah I; Wilson MD; Miller WA; Tiburu EK; Bonney JHK
Comput Biol Med; 2019 Oct; 113():103414. PubMed ID: 31536833
[TBL] [Abstract][Full Text] [Related]
35. Identification of Inhibitors against Metastasis Protein "
Mishra S; Singh S
Pharmacogn Mag; 2018 Jan; 13(Suppl 4):S742-S748. PubMed ID: 29491627
[TBL] [Abstract][Full Text] [Related]
36. In silico identification of potential inhibitors of key SARS-CoV-2 3CL hydrolase (Mpro) via molecular docking, MMGBSA predictive binding energy calculations, and molecular dynamics simulation.
Choudhary MI; Shaikh M; Tul-Wahab A; Ur-Rahman A
PLoS One; 2020; 15(7):e0235030. PubMed ID: 32706783
[TBL] [Abstract][Full Text] [Related]
37. Identification of novel protein kinase C-βII inhibitors: virtual screening, molecular docking and molecular dynamics simulation studies.
Sanapalli BKR; Yele V; Baldaniya L; Karri VVSR
J Mol Model; 2022 Apr; 28(5):117. PubMed ID: 35410409
[TBL] [Abstract][Full Text] [Related]
38. Phenolic compounds of Theobroma cacao L. show potential against dengue RdRp protease enzyme inhibition by In-silico docking, DFT study, MD simulation and MMGBSA calculation.
Huq AKMM; Roney M; Dubey A; Nasir MH; Tufail A; Aluwi MFFM; Ishak WMW; Islam MR; Tajuddin SN
PLoS One; 2024; 19(3):e0299238. PubMed ID: 38483871
[TBL] [Abstract][Full Text] [Related]
39. Combining empirical knowledge, in silico molecular docking and ADMET profiling to identify therapeutic phytochemicals from Brucea antidysentrica for acute myeloid leukemia.
Bultum LE; Tolossa GB; Lee D
PLoS One; 2022; 17(7):e0270050. PubMed ID: 35895695
[TBL] [Abstract][Full Text] [Related]
40.
Divyashri G; Krishna Murthy TP; Sundareshan S; Kamath P; Murahari M; Saraswathy GR; Sadanandan B
Bioimpacts; 2021; 11(2):119-127. PubMed ID: 33842282
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
